147 related articles for article (PubMed ID: 38478260)
21. Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells.
Li H; Zhang H; Huang G; Bing Z; Xu D; Liu J; Luo H; An X
J Exp Clin Cancer Res; 2022 Jan; 41(1):33. PubMed ID: 35073964
[TBL] [Abstract][Full Text] [Related]
22. DLC1 inhibits lung adenocarcinoma cell proliferation, migration and invasion via regulating MAPK signaling pathway.
Niu N; Ma X; Liu H; Zhao J; Lu C; Yang F; Qi W
Exp Lung Res; 2021; 47(4):173-182. PubMed ID: 33678109
[TBL] [Abstract][Full Text] [Related]
23. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of FYN suppresses the epithelial-to-mesenchymal transition through down-regulating PI3K/AKT pathway in lung adenocarcinoma.
Xue F; Jia Y; Zhao J
Surg Oncol; 2020 Jun; 33():108-117. PubMed ID: 32561075
[TBL] [Abstract][Full Text] [Related]
25. DNA repair/recombination protein 54L promotes the progression of lung adenocarcinoma by activating mTORC1 pathway.
Liu C; Ren W; Zhang Z; Guan J
Hum Cell; 2023 Jan; 36(1):421-433. PubMed ID: 36454390
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma.
Huang X; Jiang L; Lu S; Yuan M; Lin H; Li B; Wen Z; Zhong Y
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35656882
[TBL] [Abstract][Full Text] [Related]
27. Hsa_circ_0072008 regulates cell proliferation, migration, and invasion in cervical squamous cell carcinoma via miR-1305/helicase, lymphoid specific (HELLS) axis.
He C; Liu L
Bioengineered; 2022 Apr; 13(4):8311-8322. PubMed ID: 35311456
[TBL] [Abstract][Full Text] [Related]
28. Unlocking the role of EIF5A: A potential diagnostic marker regulating the cell cycle and showing negative correlation with immune infiltration in lung adenocarcinoma.
Yang Z; Yuan H; He H; Qi S; Zhu X; Hu X; Jin M; Zhang XX; Yuan ZG
Int Immunopharmacol; 2024 Jan; 126():111227. PubMed ID: 37977067
[TBL] [Abstract][Full Text] [Related]
29. KDF1 Promoted Proliferation, Migration and Invasion of Lung Adenocarcinoma Cells through Activating STAT3 and AKT Pathway.
Guo YQ; Gan MF; Bao JQ; Zhou HX; Yang J; Dai CJ; Zheng JM
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137415
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway.
Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M
Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484
[TBL] [Abstract][Full Text] [Related]
31. LINC01117 inhibits invasion and migration of lung adenocarcinoma through influencing EMT process.
Liu L; Ren W; Du L; Xu K; Zhou Y
PLoS One; 2023; 18(6):e0287926. PubMed ID: 37384755
[TBL] [Abstract][Full Text] [Related]
32. High Expression of Cancer-IgG Is Associated With Poor Prognosis and Radioresistance
Yang X; Wang G; You J; Gu R; Xu X; Xu C; Wang H; Zhao R; Qiu X; Zhu G
Front Oncol; 2021; 11():675397. PubMed ID: 34150640
[TBL] [Abstract][Full Text] [Related]
33. FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway.
Zhang J; Wang J; Yue K; Li P; Shen W; Qiao X; Wang Y; Wu X
BMC Pulm Med; 2023 Jan; 23(1):32. PubMed ID: 36690987
[TBL] [Abstract][Full Text] [Related]
34. Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway.
Shang B; Li Z; Li M; Jiang S; Feng Z; Cao Z; Wang H
Thorac Cancer; 2021 Jul; 12(14):2093-2103. PubMed ID: 34061456
[TBL] [Abstract][Full Text] [Related]
35. [S100A10 promotes proliferation and invasion of lung adenocarcinoma cells by activating the Akt-mTOR signaling pathway].
Wang H; Sun Z; Zhao W; Geng B
Nan Fang Yi Ke Da Xue Xue Bao; 2023 May; 43(5):733-740. PubMed ID: 37313814
[TBL] [Abstract][Full Text] [Related]
36. Cathepsin A knockdown decreases the proliferation and invasion of A549 lung adenocarcinoma cells.
Hu B; Zhu X; Lu J
Mol Med Rep; 2020 Jun; 21(6):2553-2559. PubMed ID: 32323791
[TBL] [Abstract][Full Text] [Related]
37. Tumor-suppressive action of miR-30a-5p in lung adenocarcinoma correlates with ABL2 inhibition and PI3K/AKT pathway inactivation.
Miao Y; Liu J
Clin Transl Oncol; 2024 Feb; 26(2):398-413. PubMed ID: 37479901
[TBL] [Abstract][Full Text] [Related]
38. CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway.
Zhang H; Cao Y; Tang J; Wang R
Biomed Res Int; 2022; 2022():9944847. PubMed ID: 35813221
[TBL] [Abstract][Full Text] [Related]
39. MiR-485-5p Suppress the Malignant Characteristics of the Lung Adenocarcinoma via Targeting NADPH Quinone Oxidoreductase-1 to Inhibit the PI3K/Akt.
Chen Y; Wu L; Bao M
Mol Biotechnol; 2023 May; 65(5):794-806. PubMed ID: 36219369
[TBL] [Abstract][Full Text] [Related]
40. IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway.
Chen X; Zhu X; Shen X; Liu Y; Fu W; Wang B
Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):370-377. PubMed ID: 36972188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
